Optimized Formulation for Topical Application of a Fixed Combination Halobetasol/Tazarotene Lotion Using Polymeric Emulsion Technology

Emil A Tanghetti; Linda Stein Gold; James Q Del Rosso; Stefan Weiss; Tina Lin; Arturo Angel; Radhakrishnan Pillai

doi:10.25251/skin.3.supp.27

Emil A Tanghetti

Center for Dermatology and Laser Surgery, Sacramento, CA

Linda Stein Gold

Henry Ford Hospital, Detroit, MI

James Q Del Rosso

JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV

Stefan Weiss

Direct Dermatology, Palo Alto, CA

Tina Lin

Ortho Dermatologics, Bridgewater, NJ

Arturo Angel

Bausch Health Americas, Inc, Petaluma, CA

Radhakrishnan Pillai

Bausch Health Americas, Inc, Petaluma, CA

Keywords

psoriasis, tazarotene, halobetasol

Abstract

Abstract not available.

References

1. Gold LS, et al. J Am Acad Dermatol. 2018;79(2):287-293.

2. Sugarman JL, et al. J Drugs Dermatol. 2017;16(3):194-201.

3. Kircik LH, et al. J Drugs Dermatol. 2019;18(3):279-284.

Poster PDF

Published

Nov 9, 2019

DOI https://doi.org/10.25251/skin.3.supp.27

How to Cite

Tanghetti, E. A., Gold, L. S., Del Rosso, J. Q., Weiss, S., Lin, T., Angel, A., & Pillai, R. (2019). Optimized Formulation for Topical Application of a Fixed Combination Halobetasol/Tazarotene Lotion Using Polymeric Emulsion Technology. SKIN The Journal of Cutaneous Medicine, 3, S27. https://doi.org/10.25251/skin.3.supp.27

Issue

Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas

Section

Poster Presentations from FC23 Dermatology Conference®: Psoriasis

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

Megan A Jones, Richard R Winkelmann, James Q Del Rosso, Status Report on the Safety of Topical Dapsone Therapy for Dermatologic Disease , SKIN The Journal of Cutaneous Medicine: Vol. 2 No. 1 (2018)
Ryan M Svoboda, James Q Del Rosso, Joshua A Zeichner, Zoe D Draelos, Revisiting the Beneficial Effects of Estrogen on the Skin: A Comprehensive Review of the Literature and a Look to the Future , SKIN The Journal of Cutaneous Medicine: Vol. 2 No. 5 (2018)
Linda Stein Gold, Mark Lebwohl, Neal Bhatia, Douglas DiRuggiero, Abby Jacobson, Radhakrishnan Pillai, Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Parth N Desai, James Q Del Rosso, Mark G Lebwohl, Clinical Manifestations and Management Considerations of Psoriasis Affecting The Nail Unit , SKIN The Journal of Cutaneous Medicine: Vol. 2 No. 1 (2018)
Mark Lebwohl, James Q Del Rosso, Chih-Ho Hong, Anna M Tailman, Leon Kircik, Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Linda Stein Gold, Jonathan S Weiss, Lawrence Green, Leon Kircik, Lauren Miller, Abby Jacobson, Susan Harris, Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients with Baseline Body Surface Area of 6 -12% , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
James Q Del Rosso, Linda Stein Gold, Leon Kircik, Neal D Bhatia, Neil Sadick, Matthew Zirwas, Edward Lain, Iain Stuart, Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Jerry Tan, James Del Rosso, Jonathan Weiss, Linda Stein Gold, Fran Cook-Bolden, Lawrence Eichenfeld, Emil Tanghetti, Alessandra Ali? Saenz, Faiz Ahmad, Trifarotene 50 µg/G Cream for Treatment of Acne Vulgaris – A Summary of Two Randomized Trials and a Long-Term Safety Study , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Robert Bissonnette, Linda Stein Gold, Leon Kircik, Stephen Tyring, Anna Tailman, April Armstrong, Efficacy of Tapinarof Cream by Body Region in Subjects With Plaque Psoriasis in a Phase 2b Randomized Controlled Study , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Linda Stein Gold, James Del Rosso, Leon Kircik, Neal D Bhatia, Deirdre Hooper, Walter Nahm, Iain Stuart, Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)

1 2 3 4 5 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Similar Articles

Most read articles by the same author(s)